🔍 Observations
Topline
- Revenue scaled 25.8% YoY (₹38,860 Cr → ₹48,873 Cr), confirming Dixon’s position as the dominant EMS play in India’s electronics manufacturing boom.
- Q4FY26 revenue at ₹10,511 Cr was broadly flat QoQ (vs ₹10,672 Cr in Q3), suggesting seasonal normalisation after a strong H2.
- Other income surged to ₹713 Cr in FY26 (vs ₹20 Cr in FY25), largely driven by a ₹670 Cr fair value/sale gain on equity investments — non-recurring in nature.
Bottomline
- Reported PAT grew 33.4% YoY (₹1,233 Cr → ₹1,644 Cr), but includes ₹460 Cr exceptional gain (FY26) vs ₹250 Cr in FY25 — distorting comparability.
- PAT attributable to owners grew 31.4% (₹1,095 Cr → ₹1,439 Cr); minority interests absorbed ₹206 Cr, reflecting rising JV/subsidiary scale.
- Core operating profit (PBT pre-exceptional, pre-JV share) rose 87.6% YoY (₹1,092 Cr → ₹2,049 Cr) — the real earnings engine.
Margins
- EBITDA (PBT pre-exceptional + Finance costs + D&A): FY26 = ₹2,049 Cr + ₹137 Cr + ₹393 Cr = ₹2,579 Cr on revenue of ₹48,873 Cr → EBITDA margin ~5.3% vs ~4.1% in FY25 (₹1,092 + ₹154 + ₹281 = ₹1,527 Cr / ₹38,860 Cr).
- Net profit margin (reported): 3.4% in FY26 vs 3.2% in FY25 — modest expansion, held back by thin EMS economics and rising depreciation (+40% YoY).
- Material cost ratio improved marginally: cost of materials at 93.0% of revenue (FY26) vs 92.9% (FY25) — essentially flat, indicating no meaningful component cost relief.
Growth Trajectory
- Revenue CAGR implied at 25%+ annualised; operating profit growth of 88% outpaced topline, signalling operating leverage beginning to kick in at scale.
- EPS (basic) grew 32% YoY (₹205.70 → ₹271.59), with dilution minimal — share count stable at ~608 lakh shares.
- Capex intensity remains high: ₹1,068 Cr in FY26 vs ₹939 Cr in FY25 (+13.7%), reflecting continued capacity build-out ahead of demand.
🧮 Profit & Loss Statement
🧮 Balance Sheet
🧮 Cash Flows Statement
🟢 Green Flags
- Operating leverage inflecting: EBITDA margin expanded ~120 bps YoY to 5.3% despite near-flat material cost ratios — scale benefits flowing through.
- Working capital reversal: Inventories released ₹196 Cr and trade receivables released ₹576 Cr in FY26, after a massive consumption in FY25 — capital efficiency normalising.
- Strong OCF generation: Operating cash flow jumped to ₹1,782 Cr (FY26) vs ₹1,150 Cr (FY25) — 55% YoY growth, validating earnings quality.
- Cash position tripled: Closing cash of ₹767 Cr vs ₹231 Cr a year ago — balance sheet liquidity strengthening materially.
- Debt remains negligible: Net debt near zero with total borrowings of ₹467 Cr against cash of ₹767 Cr — virtually ungeared for a company of this scale.
- Goodwill jump to ₹580 Cr reflects strategic acquisitions — extending into new product/customer segments that could accelerate next growth leg.
- Finance costs declining: Fell from ₹154 Cr (FY25) to ₹137 Cr (FY26) despite rising capex — reflects efficient liability management and reducing short-term debt reliance.
🔴 Red Flags
- Non-recurring income inflating PAT: ₹670 Cr investment gains within other income; strip this out and earnings quality looks materially weaker — investors must adjust.
- Exceptional item dependency: FY26 includes ₹460 Cr exceptional gains; FY25 had ₹250 Cr — back-to-back boosters mask the organic earnings trajectory.
- Depreciation accelerating: Up 40% YoY (₹281 Cr → ₹393 Cr) — capex cycle is front-loaded and will continue suppressing reported PBT growth relative to EBITDA.
- Trade payables fell ₹717 Cr YoY to ₹10,723 Cr — working capital benefit was partly from payable compression, which may not recur and could reverse.
- Goodwill jumped from ₹57 Cr to ₹580 Cr — acquisition-led; impairment risk exists if acquired entities underperform; needs monitoring.
- Current tax expense more than doubled: ₹413 Cr vs ₹253 Cr in FY25 — effective tax rate rising as exemptions or incentives taper.
- MSME payables nearly doubled (₹78 Cr → ₹166 Cr) — rising dependency on smaller vendors; regulatory risk under MSME payment norms.
📊 Balance Sheet Analysis
- Asset quality solid: Gross block (PPE + CWIP) grew from ₹2,365 Cr to ₹3,290 Cr — productive asset base expanding; no signs of asset impairment or bloat.
- Equity base strengthened significantly: Total equity rose from ₹3,469 Cr to ₹5,387 Cr, driven by retained earnings and NCI contributions — book value per share rising.
- Liquidity comfortable: Current ratio = ₹13,515 Cr / ₹12,698 Cr = 1.06x — thin but stable; trade payables dominate current liabilities, which is structural for EMS.
- Leverage negligible: Total borrowings of ₹467 Cr vs equity of ₹5,387 Cr → Debt/Equity of 0.09x — fortress balance sheet for an asset-light-to-moderate EMS model.
💰 Cash Flow Analysis
- OCF of ₹1,782 Cr (FY26) fully funds capex of ₹1,068 Cr — free cash flow of ~₹714 Cr, a meaningful positive for the first time at scale.
- Working capital tailwind of ₹43 Cr in FY26 (vs a ₹4.28 Cr drag in FY25) — driven by receivables and inventory release; sustainability depends on revenue mix holding.
- Investing outflows of ₹1,251 Cr include ₹1,056 Cr in net mutual fund flows (mostly churn) and ₹431 Cr in subsidiary investments — M&A appetite remains active.
- Financing cash outflow of ₹108 Cr is modest — fresh equity issuance of ₹247 Cr partially offsets debt repayment and dividend of ₹118 Cr; balance sheet self-funded.
💡 Investment Outlook
Dixon delivered a genuinely strong FY26 — OCF inflection, EBITDA margin expansion, and a fortress balance sheet validate the structural EMS thesis.
However, back-to-back exceptional gains and investment income have inflated reported PAT, requiring investors to use adjusted earnings (operating PBT basis) for valuation.
At current scale, operating leverage is real but incremental — the next leg of margin improvement will depend on product mix premiumisation (mobile, wearables, IT hardware) rather than pure volume.
The company remains a high-conviction structural compounder, but rich valuations leave little room for execution misses.
Disclaimer: This post features ChartAlert-AI-generated financial content which may contain inaccuracies or errors. This commentary is strictly for informational purposes and does not constitute a recommendation to buy or sell any security. Investors are responsible for performing their own due diligence; always consult with a licensed financial advisor before making investment decisions.
Beyond the Price Action: Fundamental Analysis is Coming to ChartAlert
ChartAlert is evolving into integrated research with a future update that will embed fundamental data into your workflow. Alongside technical analysis, the new release will allow access to financial data, quarterly results review, earnings call transcripts, and valuation tools, connecting price action with corporate performance for smarter, data‑driven decisions.